EFM
CERE

E Fund Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

E Fund Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,132
Closed -$455K – 375
2024
Q2 		$455K Buy
11,132
+626
+6% +$26.1K 0.03% 186
2024
Q1 		$444K Buy
10,506
+2,907
+38% +$122K 0.03% 179
2023
Q4 		$322K Sell
7,599
-2,624
-26% -$75.4K 0.02% 221
2023
Q3 		$223K Buy
10,223
+722
+8% +$18.1K 0.02% 241
2023
Q2 		$302K Sell
9,501
-2,431
-20% -$74.6K 0.02% 216
2023
Q1 		$291K Sell
11,932
-577
-5% -$16.9K 0.02% 230
2022
Q4 		$395K Buy
12,509
+2,109
+20% +$59.5K 0.03% 182
2022
Q3 		$294K Buy
10,400
+1,916
+23% +$57.1K 0.03% 242
2022
Q2 		$224K Buy
+8,484
New +$241K 0.02% 281

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

E Fund Management's CERE Position: Q3 2024 in Review

E Fund Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 11,132 shares — an estimated $455K sold.

E Fund Management first reported a position in CERE in Q2 2022 and held it in 9 quarters. The position peaked at $455K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • E Fund Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • E Fund Management sold 11,132 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $455K.
  • E Fund Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 9 quarters.
  • E Fund Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $455K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.